Antimicrobial peptides: features, action, and their resistance mechanisms in bacteria

H Moravej, Z Moravej, M Yazdanparast… - Microbial Drug …, 2018 - liebertpub.com
In recent years, because of increased resistance to conventional antimicrobials, many
researchers have started to study the synthesis of new antibiotics to control the disease …

[HTML][HTML] Emerging peptide antibiotics with therapeutic potential

G Upert, A Luther, D Obrecht, P Ermert - Medicine in drug discovery, 2021 - Elsevier
This review covers some of the recent progress in the field of peptide antibiotics with a focus
on compounds with novel or established mode of action and with demonstrated efficacy in …

Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum

R Böttger, R Hoffmann, D Knappe - PloS one, 2017 - journals.plos.org
Proteolytic degradation of peptide-based drugs is often considered as major weakness
limiting systemic therapeutic applications. Therefore, huge efforts are typically devoted to …

Structure–Activity Relationships of the Antimicrobial Peptide Natural Product Apidaecin

KJ Skowron, C Baliga, T Johnson… - Journal of medicinal …, 2023 - ACS Publications
With the growing crisis of antimicrobial resistance, it is critical to continue to seek out new
sources of novel antibiotics. This need has led to renewed interest in natural product …

Yeast-based synthetic biology platform for antimicrobial peptide production

J Cao, C de la Fuente-Nunez, RW Ou… - ACS synthetic …, 2018 - ACS Publications
Antibiotic resistance is one of the most challenging global health threats in our society.
Antimicrobial peptides (AMPs) represent promising alternatives to conventional antibiotics …

Multidrug resistance (MDR) and collateral sensitivity in bacteria, with special attention to genetic and evolutionary aspects and to the perspectives of antimicrobial …

A Fodor, BA Abate, P Deák, L Fodor, E Gyenge… - Pathogens, 2020 - mdpi.com
Antibiotic poly-resistance (multidrug-, extreme-, and pan-drug resistance) is controlled by
adaptive evolution. Darwinian and Lamarckian interpretations of resistance evolution are …

Spermine-conjugated short proline-rich lipopeptides as broad-spectrum intracellular targeting antibacterial agents

RP Dewangan, DP Verma, NK Verma… - Journal of Medicinal …, 2022 - ACS Publications
Toward the design of new proline-rich peptidomimetics, a short peptide segment, present in
several proline-rich antimicrobial peptides (AMPs), was selected. Fatty acids of varying …

Host–pathogen immune feedbacks can explain widely divergent outcomes from similar infections

SP Ellner, N Buchon, T Dörr… - Proceedings of the …, 2021 - royalsocietypublishing.org
A long-standing question in infection biology is why two very similar individuals, with very
similar pathogen exposures, may have very different outcomes. Recent experiments have …

Evaluation of proline-rich antimicrobial peptides as potential lead structures for novel antimycotics against Cryptococcus neoformans

A Brakel, T Grochow, S Fritsche, D Knappe… - Frontiers in …, 2024 - frontiersin.org
Background Cryptococcosis and cryptococcal meningitis, caused by Cryptococcus
neoformans infections, lead to approximately 180,000 deaths per year, primarily in …

Caprine bactenecins as promising tools for developing new antimicrobial and antitumor drugs

PM Kopeikin, MS Zharkova, AA Kolobov… - Frontiers in cellular …, 2020 - frontiersin.org
Proline-rich antimicrobial peptides (PR-AMPs) having a potent antimicrobial activity
predominantly toward Gram-negative bacteria and negligible toxicity toward host cells, are …